Takeda Pharmaceutical Co (TSE:4502) Cyclically Adjusted Book per Share: 円3,836.67 (As of Mar. 2026)


TSE:4502 Takeda Pharmaceutical Co Ltd TSE:4502
65 GF Score
Price 円5,517.00
GF Value 円4,535.49
Valuation Modestly Overvalued
! 9 Warning Signs
View Full Analysis

What is Takeda Pharmaceutical Co Cyclically Adjusted Book per Share?

Takeda Pharmaceutical Co TSE:4502 +2.95% 65 Cyclically Adjusted Book per Share is 円3,836.67 as of Mar. 2026. GuruFocus rates TSE:4502 with a GF Score™ of 65/100 and a GF Value™ of 円4,535.49 (Modestly Overvalued). The stock has 9 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Takeda Pharmaceutical Co's adjusted book value per share for the three months ended in Mar. 2026 was 円4,702.663. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is 円3,836.67 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Takeda Pharmaceutical Co's average Cyclically Adjusted Book Growth Rate was 5.80% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 6.50% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 6.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Takeda Pharmaceutical Co was 7.10% per year. The lowest was 1.30% per year. And the median was 4.00% per year.

As of today (2026-07-07), Takeda Pharmaceutical Co's current stock price is 円5517.00. Takeda Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was 円3,836.67. Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is 1.44.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Takeda Pharmaceutical Co was 2.42. The lowest was 1.03. And the median was 1.34.


Takeda Pharmaceutical Co  (TSE:4502) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=5517.00/3836.67
=1.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Takeda Pharmaceutical Co was 2.42. The lowest was 1.03. And the median was 1.34.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Takeda Pharmaceutical Co Cyclically Adjusted Book per Share Related Terms


Takeda Pharmaceutical Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Takeda Pharmaceutical Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Takeda Pharmaceutical Co Cyclically Adjusted Book per Share Chart

Takeda Pharmaceutical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,947.80 3,174.37 3,377.52 3,626.07 3,836.67

Takeda Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,626.07 3,677.35 3,723.45 3,800.77 3,836.67

TSE:4502 vs ZTS, UTHR: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Takeda Pharmaceutical Co Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Takeda Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.


TSE:4502
65GF Score
Takeda Pharmaceutical Co Ltd TSE:4502
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Takeda Pharmaceutical Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Takeda Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=4702.663/112.7000*112.7000
=4,702.663

Current CPI (Mar. 2026) = 112.7000.

Takeda Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201606 2,308.177 98.100 2,651.698
201609 2,321.385 98.000 2,669.593
201612 2,528.598 98.400 2,896.067
201703 2,425.924 98.100 2,786.969
201706 2,579.194 98.500 2,951.017
201709 2,669.927 98.800 3,045.554
201712 2,705.506 99.400 3,067.510
201803 2,556.510 99.200 2,904.422
201806 2,615.469 99.200 2,971.405
201809 2,775.239 99.900 3,130.825
201812 2,609.269 99.700 2,949.495
201903 3,332.938 99.700 3,767.524
201906 3,132.509 99.800 3,537.412
201909 3,123.559 100.100 3,516.734
201912 3,127.644 100.500 3,507.318
202003 3,032.216 100.300 3,407.086
202006 2,998.373 99.900 3,382.549
202009 2,982.303 99.900 3,364.420
202012 2,965.003 99.300 3,365.114
202103 3,308.927 99.900 3,732.894
202106 3,339.331 99.500 3,782.338
202109 3,384.940 100.100 3,811.016
202112 3,423.016 100.100 3,853.885
202203 3,643.879 101.100 4,061.970
202206 4,085.656 101.800 4,523.118
202209 4,318.321 103.100 4,720.415
202212 3,972.906 104.100 4,301.119
202303 4,087.490 104.400 4,412.453
202306 4,452.063 105.200 4,769.463
202309 4,506.601 106.200 4,782.429
202312 4,297.220 106.800 4,534.613
202403 4,635.566 107.200 4,873.398
202406 4,970.047 108.200 5,176.750
202409 4,365.908 108.900 4,518.254
202412 4,679.771 110.700 4,764.320
202503 4,407.005 111.100 4,470.472
202506 4,395.189 111.700 4,434.537
202509 4,514.259 112.000 4,542.473
202512 4,838.543 113.000 4,825.697
202603 4,702.663 112.700 4,702.663

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of 円3,836.67 mean?
Takeda Pharmaceutical Co (TSE:4502) has a Cyclically Adjusted Book per Share of 円3,836.67 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Takeda Pharmaceutical Co and its competitors.
Is Takeda Pharmaceutical Co's Cyclically Adjusted Book per Share too high?
Takeda Pharmaceutical Co's current Cyclically Adjusted Book per Share is 円3,836.67. Overall, Takeda Pharmaceutical Co has a GF Score™ of 65/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Takeda Pharmaceutical Co's Cyclically Adjusted Book per Share compare to ZTS and UTHR?
Takeda Pharmaceutical Co's Cyclically Adjusted Book per Share of 円3,836.67 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Takeda Pharmaceutical Co and its competitors. Takeda Pharmaceutical Co's current Cyclically Adjusted Book per Share is 円3,836.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Takeda Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Takeda Pharmaceutical Co (TSE:4502) is currently considered Modestly Overvalued. The stock's GF Value™ is 円4,535.49, compared to a current price of 円5,517.00 — trading 21.6% above its estimated fair value. The current Cyclically Adjusted Book per Share is 円3,836.67. Takeda Pharmaceutical Co's overall GF Score™ is 65/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Takeda Pharmaceutical Co (TSE:4502), the current Cyclically Adjusted Book per Share is 円3,836.67 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Takeda Pharmaceutical Co (TSE:4502) Overvalued in 2026?

Based on GuruFocus' analysis, Takeda Pharmaceutical Co stock appears to be overvalued. The current stock price of 円5,517.00 is trading 21.6% above its estimated GF Value™ of 円4,535.49. GuruFocus considers Takeda Pharmaceutical Co to be Modestly Overvalued.

Key valuation signals for TSE:4502:

  • Cyclically Adjusted Book per Share: 円3,836.67
  • GF Value™: 円4,535.49 vs. price of 円5,517.00 (21.6% above fair value)
  • GF Score™: 65/100 with 9 warning signs

No single metric tells the full story. See the TSE:4502 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Takeda Pharmaceutical Co Business Description

Address 1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.5 trillion in fiscal 2025. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with about 50% from the US, 10% from Japan, 25% from Europe, and 15% from Canada.
65GF Score

Get the complete analysis for TSE:4502

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円5,517.00
Price
円4,535.49
GF Value